JBIO vs. HOOD
JBIO (Jade Biosciences, Inc) and HOOD (Robinhood Markets, Inc.) are both stocks. JBIO operates in Biotechnology (Healthcare), while HOOD operates in Capital Markets (Financial Services). Over the past 3 years, JBIO returned 126.60%/yr vs 123.33%/yr for HOOD. At a 0.23 correlation, their price movements are largely independent.
Performance
JBIO vs. HOOD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JBIO achieves a 26.05% return, which is significantly higher than HOOD's -6.53% return.
JBIO
- 1D
- 15.64%
- 1M
- -12.43%
- YTD
- 26.05%
- 6M
- 15.29%
- 1Y
- 96.66%
- 3Y*
- 126.60%
- 5Y*
- —
- 10Y*
- —
HOOD
- 1D
- -2.26%
- 1M
- 43.55%
- YTD
- -6.53%
- 6M
- -13.61%
- 1Y
- 34.66%
- 3Y*
- 123.33%
- 5Y*
- —
- 10Y*
- —
JBIO vs. HOOD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
JBIO Jade Biosciences, Inc | 26.05% | 5,473.10% | -88.29% | -22.76% | 148.52% | -11.02% |
HOOD Robinhood Markets, Inc. | -6.53% | 203.54% | 192.46% | 56.51% | -54.17% | -53.26% |
Correlation
The correlation between JBIO and HOOD is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Jul 29, 2021 | 0.23 |
Fundamentals
JBIO:
$1.12B
HOOD:
$96.73B
JBIO:
-$2.96
HOOD:
$2.07
JBIO:
3.79
HOOD:
9.98
JBIO:
$0.00
HOOD:
$3.91B
JBIO:
-$9.00K
HOOD:
$2.86B
JBIO:
-$133.57M
HOOD:
$1.80B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JBIO vs. HOOD — Risk / Return Rank
JBIO
HOOD
JBIO vs. HOOD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Jade Biosciences, Inc (JBIO) and Robinhood Markets, Inc. (HOOD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JBIO | HOOD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.74 | ||
| Sortino ratioReturn per unit of downside risk | +0.79 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.14 | +0.10 |
| Calmar ratioReturn relative to maximum drawdown | 2.20 | 0.61 | +1.59 |
| Martin ratioReturn relative to average drawdown | 4.83 | 1.09 | +3.74 |
Loading charts...
Drawdowns
JBIO vs. HOOD - Drawdown Comparison
The maximum JBIO drawdown since its inception was -95.41%, which is greater than HOOD's maximum drawdown of -90.21%. Use the drawdown chart below to compare losses from any high point for JBIO and HOOD.
Loading charts...
Drawdown Indicators
| JBIO | HOOD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.41% | -90.21% | -5.20% |
Max Drawdown (1Y)Largest decline over 1 year | -44.21% | -57.26% | +13.05% |
Max Drawdown (3Y)Largest decline over 3 years | -95.41% | -57.26% | -38.15% |
Current DrawdownCurrent decline from peak | -27.56% | -30.66% | +3.10% |
Average DrawdownAverage peak-to-trough decline | -45.13% | -60.74% | +15.61% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.10% | 32.02% | -11.92% |
Volatility
JBIO vs. HOOD - Volatility Comparison
Jade Biosciences, Inc (JBIO) has a higher volatility of 28.03% compared to Robinhood Markets, Inc. (HOOD) at 23.34%. This indicates that JBIO's price experiences larger fluctuations and is considered to be riskier than HOOD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JBIO | HOOD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 28.03% | 23.34% | +4.69% |
Volatility (6M)Calculated over the trailing 6-month period | 54.75% | 50.73% | +4.02% |
Volatility (1Y)Calculated over the trailing 1-year period | 78.78% | 69.85% | +8.93% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 1,584.51% | 74.07% | +1,510.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 1,584.51% | 74.07% | +1,510.44% |
Dividends
JBIO vs. HOOD - Dividend Comparison
Neither JBIO nor HOOD has paid dividends to shareholders.
| Position | TTM | 2025 |
|---|---|---|
HOOD Robinhood Markets, Inc. | 0.00% | 0.00% |
JBIO Jade Biosciences, Inc | 0.00% | 15.55% |
Financials
JBIO vs. HOOD - Financials Comparison
This section allows you to compare key financial metrics between Jade Biosciences, Inc and Robinhood Markets, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
JBIO and HOOD have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
JBIO has higher volatility (28.03%) compared to HOOD (23.34%). In terms of maximum drawdown, JBIO dropped -95.41% vs HOOD's -90.21%.
JBIO currently has the higher Sharpe Ratio (1.24 vs 0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JBIO and HOOD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer